Cockayne syndrome: Clinical features, model systems and pathways.
Karikkineth AC, Scheibye-Knudsen M, Fivenson E, Croteau DL, Bohr VA.
Ageing Res Rev. 2017 Jan;33:3-17. doi: 10.1016/j.arr.2016.08.002. Epub 2016 Aug 6.
Xeroderma pigmentosum-Cockayne syndrome complex.
Natale V, Raquer H.
Orphanet J Rare Dis. 2017 Apr 4;12(1):65. doi: 10.1186/s13023-017-0616-2.
[Cockayne Syndrome].
Moriwaki S.
Brain Nerve. 2019 Apr;71(4):390-393. doi: 10.11477/mf.1416201282.
Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer.
Spyropoulou Z, Papaspyropoulos A, Lagopati N, Myrianthopoulos V, Georgakilas AG, Fousteri M, Kotsinas A, Gorgoulis VG.
Cells. 2021 Apr 10;10(4):866. doi: 10.3390/cells10040866.
Role of Cockayne Syndrome Group B Protein in Replication Stress: Implications for Cancer Therapy.
Walker JR, Zhu XD.
Int J Mol Sci. 2022 Sep 6;23(18):10212. doi: 10.3390/ijms231810212.
Xeroderma pigmentosum-Cockayne syndrome complex.
Dev N, Aggarwal P.
Indian J Med Res. 2020 Nov;152(Suppl 1):S74-S75. doi: 10.4103/ijmr.IJMR_2097_19.
Cockayne Syndrome Linked to Elevated R-Loops Induced by Stalled RNA Polymerase II during Transcription Elongation.
Zhang X, Xu J, Hu J, Zhang S, Hao Y, Zhang D, Qian H, Wang D, Fu XD.
Nat Commun. 2024 Jul 17;15(1):6031. doi: 10.1038/s41467-024-50298-w.
Cockayne syndrome and xeroderma pigmentosum.
Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH.
Neurology. 2000 Nov 28;55(10):1442-9. doi: 10.1212/wnl.55.10.1442.
Cockayne syndrome pathogenesis: lessons from mouse models.
Jaarsma D, van der Pluijm I, van der Horst GT, Hoeijmakers JH.
Mech Ageing Dev. 2013 May-Jun;134(5-6):180-95. doi: 10.1016/j.mad.2013.04.003. Epub 2013 Apr 13.
Cockayne syndrome without UV-sensitivity in Vietnamese siblings with novel ERCC8 variants.
Duong NT, Dinh TH, Möhl BS, Hintze S, Quynh DH, Ha DTT, Ngoc ND, Dung VC, Miyake N, Hai NV, Matsumoto N, Meinke P.
Aging (Albany NY). 2022 Jun 22;14(13):5299-5310. doi: 10.18632/aging.204139. Epub 2022 Jun 22.
